van der Vaart Sandra D
SEC CIK 1537208 · EDGAR
BoughtSold
Most active insiders at LH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| 2 | Parham Richelle P | Dir | — | $1.78M |
| 3 | Wilkinson Peter J | SVP, CAO | — | $1.06M |
| 4 | ANDERSON KERRII B | Dir | — | $954.1K |
| 5 | Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| 6 | Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| 7 | Summy Amy B. | EVP, CMO | — | $283.4K |
| 8 | Kyle Kathryn W | EVP, CLO | — | $227.4K |
| 9 | van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| 10 | Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Transactions 58
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-26 | LH | Labcorp | van der Vaart Sandra D | EVP, Corp. Affairs | A - Grant | $0.00 | +6,382 | 8,961 | +247% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Labcorp | van der Vaart Sandra D | EVP, Corp. Affairs | F - Tax | $268.38 | -2,722 | 6,239 | -30% | -$730.5K | |
| 2026-03-03 | 2026-02-27 | LH | Labcorp | van der Vaart Sandra D | EVP, Corp. Affairs | S - Sale | $284.91 | -547.54 | 2,579 | -18% | -$156.0K | |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | van der Vaart Sandra D | EVP, Corp. Affairs | F - Tax | $289.89 | -99 | 3,126 | -3% | -$28.7K |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | van der Vaart Sandra D | EVP, Corp. Affairs | M - OptEx | — | +376 | 3,225 | +13% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | van der Vaart Sandra D | EVP, Corp. Affairs | M - OptEx | — | +740 | 2,690 | +38% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | van der Vaart Sandra D | EVP, Corp. Affairs | F - Tax | $275.67 | -194 | 2,589 | -7% | -$53.5K |
| D | 2025-08-15 | 2025-08-13 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | $131.43 | +3,903 | 6,177 | +172% | +$513.0K |
| D | 2025-08-15 | 2025-08-13 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $271.42 | -3,903 | 2,274 | -63% | -$1.06M |
| 2025-05-05 | 2025-05-01 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $238.36 | -1,900 | 2,244 | -46% | -$452.9K | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $231.67 | -1,352 | 4,144 | -25% | -$313.2K | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | A - Grant | $0.00 | +3,325 | 5,496 | +153% | $0 | |
| 2025-02-27 | 2025-02-25 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $251.30 | -1,314 | 2,171 | -38% | -$330.2K | |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $245.14 | -86 | 3,485 | -2% | -$21.1K |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +323 | 3,571 | +10% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $247.03 | -196 | 3,248 | -6% | -$48.4K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +740 | 3,090 | +31% | — |
| 2024-11-25 | 2024-11-21 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $239.42 | -1,000 | 2,670 | -27% | -$239.4K | |
| 2024-08-21 | 2024-08-19 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $227.05 | -2,000 | 3,670 | -35% | -$454.1K | |
| M | 2024-05-16 | 2024-05-14 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $210.83 | -2,000 | 5,837 | -26% | -$421.7K |
| D | 2024-03-29 | 2024-03-28 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $216.74 | -3,553 | 7,637 | -32% | -$770.1K |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +6,158 | 13.8K | +81% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $216.57 | -2,605 | 11.2K | -19% | -$564.2K |
| 2024-02-15 | 2024-02-13 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $226.45 | -237 | 7,637 | -3% | -$53.7K | |
| D | 2024-02-13 | 2024-02-12 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $227.45 | -87 | 7,874 | -1% | -$19.8K |
| D | 2024-02-13 | 2024-02-11 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +324 | 7,961 | +4% | — |
| 2024-02-09 | 2024-02-08 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $222.06 | -259 | 7,637 | -3% | -$57.5K | |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +353 | 7,990 | +5% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $223.71 | -94 | 7,896 | -1% | -$21.0K |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +264 | 7,901 | +3% | — |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $221.54 | -71 | 7,830 | -0.9% | -$15.7K |
| D | 2024-02-06 | 2024-02-05 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $220.57 | -193 | 7,637 | -2% | -$42.6K |
| 2023-07-03 | 2023-06-29 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $240.00 | -212 | 7,605 | -3% | -$50.9K | |
| 2023-06-21 | 2023-06-20 | FTRE | Fortrea Holdings Inc. | van der Vaart Sandra D | Pres, Sec, Dir | J - Other | $0.00 | +7,816 | 7,816 | New | $0 | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | A - Grant | $0.00 | +3,609 | 9,162 | +65% | $0 | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $224.70 | -1,371 | 7,791 | -15% | -$308.1K | |
| D | 2023-02-14 | 2023-02-13 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $248.13 | -78 | 5,553 | -1% | -$19.4K |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +290 | 5,631 | +5% | — |
| D | 2023-02-09 | 2023-02-07 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $243.01 | -219 | 5,341 | -4% | -$53.2K |
| D | 2023-02-07 | 2023-02-06 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $244.50 | -81 | 5,560 | -1% | -$19.8K |
| D | 2023-02-07 | 2023-02-04 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +300 | 5,641 | +6% | — |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +237 | 5,578 | +4% | — |
| D | 2023-02-06 | 2023-02-03 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $253.90 | -173 | 5,341 | -3% | -$43.9K |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $254.99 | -64 | 5,514 | -1% | -$16.3K |
| 2022-03-31 | 2022-03-29 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $277.11 | -2,449 | 5,287 | -32% | -$678.6K | |
| 2022-03-29 | 2022-03-28 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $276.42 | -1,792 | 7,736 | -19% | -$495.3K | |
| 2022-03-29 | 2022-03-27 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | A - Grant | $0.00 | +4,241 | 9,528 | +80% | $0 | |
| 2022-02-17 | 2022-02-15 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale | $273.98 | -207 | 5,287 | -4% | -$56.7K | |
| D | 2022-02-15 | 2022-02-12 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +284 | 5,571 | +5% | — |
| D | 2022-02-15 | 2022-02-14 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $272.68 | -77 | 5,494 | -1% | -$21.0K |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $277.48 | -82 | 5,505 | -1% | -$22.8K |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +300 | 5,587 | +6% | — |
| D | 2022-02-08 | 2022-02-07 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $277.38 | -218 | 5,287 | -4% | -$60.5K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +236 | 5,523 | +4% | — |
| D | 2022-02-04 | 2022-02-03 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $271.81 | -172 | 5,287 | -3% | -$46.8K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | F - Tax | $273.18 | -64 | 5,459 | -1% | -$17.5K |
| D | 2021-09-17 | 2021-09-15 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | M - OptEx | $84.86 | +4,500 | 9,765 | +85% | +$381.9K |
| D | 2021-09-17 | 2021-09-15 | LH | Labcorp | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $296.78 | -4,500 | 5,265 | -46% | -$1.34M |
Purchase Sale Sale after option exercise All abbreviations